Radiomic features in recurrent/metastatic platinum refractory head and neck squamous cell carcinoma treated with immunotherapy.

被引：1
|
作者：
Anile, Giuseppe
Bettinelli, Andrea
Paiusco, Marta
De Conti, Giorgio
Gottardi, Chiara
Conte, Pierfranco
Ghi, Maria Grazia
机构：
[1] Veneto Inst Oncol IOV IRCCS, Oncol Unit 2, Padua, Italy
[2] Univ Padua, Dept Informat Engn DEI, Padua, Italy
[3] Veneto Inst Oncol IOV IRCCS, Dept Med Phys, Padua, Italy
[4] Padua Univ, AOP, Dept Radiol, Padua, Italy
[5] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[6] Veneto Inst Oncol IOV IRCCS, Oncol Unit 2, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e18000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18000
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Radiomic biomarkers for platinum-refractory head and neck cancer in the era of immunotherapy
    Lu, Hsueh-Ju
    Shen, Chao-Yu
    Chiu, Yu-Wei
    Lin, Wea-Lung
    Peng, Chih-Yu
    Tseng, Hsien-Chun
    Hsin, Chung-Han
    Chuang, Chun-Yi
    Chen, Chun-Chia
    Wu, Ming-Fang
    Huang, Wei-Shiou
    Shen, Wei-Chih
    ORAL DISEASES, 2024,
  • [32] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
  • [33] Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Greenhalgh, J.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    McLeod, C.
    Dundar, Y.
    Proudlove, C.
    Shaw, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [34] Therapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma
    Gauduchon, Thibault
    Neidhardt, Eve Marie
    Fayette, Jerome
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) : 175 - 183
  • [35] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [36] Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
    Mirabile, Aurora
    Miceli, Rosalba
    Calderone, Rosa Gioia
    Locati, Laura
    Bossi, Paolo
    Bergamini, Cristiana
    Granata, Roberta
    Perrone, Federica
    Mariani, Luigi
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1895 - 1902
  • [37] Prognostic Factors in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Rosko, A.
    Heft-Neal, M. E.
    Shuman, A.
    Brenner, J. C.
    Worden, F.
    Spector, M. E.
    Swiecicki, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1177 - 1177
  • [38] Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Kornek, V
    Scheithauer, W
    Glaser, C
    Toth, J
    Duman, M
    Formanek, M
    Hejna, M
    Kornfehl, J
    ONCOLOGY, 1999, 56 (01) : 24 - 27
  • [39] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [40] Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma
    Ducoulombier, Agnes
    Guigay, Joel
    Etienne-Grimaldi, Marie-Christine
    Saada-Bouzid, Esma
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 166 - 177
12345